ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Interleukin 17A Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-1R10044
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Interleukin 17A Market Insights Forecast to 2028
BUY CHAPTERS

Global Interleukin 17A Market Research Report 2025

Code: QYRE-Auto-1R10044
Report
January 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Abeome Corporation
Affibody AB
Cell Medica Limited
Eli Lilly and Company
Johnson & Johnson
Merck KGaA
Novartis
Orega Biotech SAS

Interleukin 17A Market

The global market for Interleukin 17A was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Interleukin 17A is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Interleukin 17A is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Interleukin 17A include AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG, Orega Biotech SAS, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Interleukin 17A, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interleukin 17A.
The Interleukin 17A market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Interleukin 17A market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interleukin 17A manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Interleukin 17A Market Report

Report Metric Details
Report Name Interleukin 17A Market
Segment by Type
  • ABY-035
  • CNTO-6785
  • DLX-2882
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG, Orega Biotech SAS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Interleukin 17A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Interleukin 17A in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Interleukin 17A Market report?

Ans: The main players in the Interleukin 17A Market are AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG, Orega Biotech SAS

What are the Application segmentation covered in the Interleukin 17A Market report?

Ans: The Applications covered in the Interleukin 17A Market report are Chronic Pain, Liver Cancer, Kidney Cancer, Others

What are the Type segmentation covered in the Interleukin 17A Market report?

Ans: The Types covered in the Interleukin 17A Market report are ABY-035, CNTO-6785, DLX-2882, Others

Recommended Reports

Autoimmune & Immunology

Cancer Diagnostics & Therapy

Diagnostics & Monitoring

1 Interleukin 17A Market Overview
1.1 Product Definition
1.2 Interleukin 17A by Type
1.2.1 Global Interleukin 17A Market Value Comparison by Type (2024 VS 2031)
1.2.2 ABY-035
1.2.3 CNTO-6785
1.2.4 DLX-2882
1.2.5 Others
1.3 Interleukin 17A by Application
1.3.1 Global Interleukin 17A Market Value by Application (2024 VS 2031)
1.3.2 Chronic Pain
1.3.3 Liver Cancer
1.3.4 Kidney Cancer
1.3.5 Others
1.4 Global Interleukin 17A Market Size Estimates and Forecasts
1.4.1 Global Interleukin 17A Revenue 2020-2031
1.4.2 Global Interleukin 17A Sales 2020-2031
1.4.3 Global Interleukin 17A Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Interleukin 17A Market Competition by Manufacturers
2.1 Global Interleukin 17A Sales Market Share by Manufacturers (2020-2025)
2.2 Global Interleukin 17A Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Interleukin 17A Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Interleukin 17A, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Interleukin 17A, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Interleukin 17A, Product Type & Application
2.7 Global Key Manufacturers of Interleukin 17A, Date of Enter into This Industry
2.8 Global Interleukin 17A Market Competitive Situation and Trends
2.8.1 Global Interleukin 17A Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Interleukin 17A Players Market Share by Revenue
2.8.3 Global Interleukin 17A Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Interleukin 17A Market Scenario by Region
3.1 Global Interleukin 17A Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Interleukin 17A Sales by Region: 2020-2031
3.2.1 Global Interleukin 17A Sales by Region: 2020-2025
3.2.2 Global Interleukin 17A Sales by Region: 2026-2031
3.3 Global Interleukin 17A Revenue by Region: 2020-2031
3.3.1 Global Interleukin 17A Revenue by Region: 2020-2025
3.3.2 Global Interleukin 17A Revenue by Region: 2026-2031
3.4 North America Interleukin 17A Market Facts & Figures by Country
3.4.1 North America Interleukin 17A Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Interleukin 17A Sales by Country (2020-2031)
3.4.3 North America Interleukin 17A Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Interleukin 17A Market Facts & Figures by Country
3.5.1 Europe Interleukin 17A Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Interleukin 17A Sales by Country (2020-2031)
3.5.3 Europe Interleukin 17A Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Interleukin 17A Market Facts & Figures by Region
3.6.1 Asia Pacific Interleukin 17A Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Interleukin 17A Sales by Region (2020-2031)
3.6.3 Asia Pacific Interleukin 17A Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Interleukin 17A Market Facts & Figures by Country
3.7.1 Latin America Interleukin 17A Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Interleukin 17A Sales by Country (2020-2031)
3.7.3 Latin America Interleukin 17A Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Interleukin 17A Market Facts & Figures by Country
3.8.1 Middle East and Africa Interleukin 17A Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Interleukin 17A Sales by Country (2020-2031)
3.8.3 Middle East and Africa Interleukin 17A Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Interleukin 17A Sales by Type (2020-2031)
4.1.1 Global Interleukin 17A Sales by Type (2020-2025)
4.1.2 Global Interleukin 17A Sales by Type (2026-2031)
4.1.3 Global Interleukin 17A Sales Market Share by Type (2020-2031)
4.2 Global Interleukin 17A Revenue by Type (2020-2031)
4.2.1 Global Interleukin 17A Revenue by Type (2020-2025)
4.2.2 Global Interleukin 17A Revenue by Type (2026-2031)
4.2.3 Global Interleukin 17A Revenue Market Share by Type (2020-2031)
4.3 Global Interleukin 17A Price by Type (2020-2031)
5 Segment by Application
5.1 Global Interleukin 17A Sales by Application (2020-2031)
5.1.1 Global Interleukin 17A Sales by Application (2020-2025)
5.1.2 Global Interleukin 17A Sales by Application (2026-2031)
5.1.3 Global Interleukin 17A Sales Market Share by Application (2020-2031)
5.2 Global Interleukin 17A Revenue by Application (2020-2031)
5.2.1 Global Interleukin 17A Revenue by Application (2020-2025)
5.2.2 Global Interleukin 17A Revenue by Application (2026-2031)
5.2.3 Global Interleukin 17A Revenue Market Share by Application (2020-2031)
5.3 Global Interleukin 17A Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie Inc
6.1.1 AbbVie Inc Company Information
6.1.2 AbbVie Inc Description and Business Overview
6.1.3 AbbVie Inc Interleukin 17A Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Inc Interleukin 17A Product Portfolio
6.1.5 AbbVie Inc Recent Developments/Updates
6.2 Abeome Corporation
6.2.1 Abeome Corporation Company Information
6.2.2 Abeome Corporation Description and Business Overview
6.2.3 Abeome Corporation Interleukin 17A Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abeome Corporation Interleukin 17A Product Portfolio
6.2.5 Abeome Corporation Recent Developments/Updates
6.3 Affibody AB
6.3.1 Affibody AB Company Information
6.3.2 Affibody AB Description and Business Overview
6.3.3 Affibody AB Interleukin 17A Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Affibody AB Interleukin 17A Product Portfolio
6.3.5 Affibody AB Recent Developments/Updates
6.4 Cell Medica Limited
6.4.1 Cell Medica Limited Company Information
6.4.2 Cell Medica Limited Description and Business Overview
6.4.3 Cell Medica Limited Interleukin 17A Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cell Medica Limited Interleukin 17A Product Portfolio
6.4.5 Cell Medica Limited Recent Developments/Updates
6.5 Eli Lilly and Company
6.5.1 Eli Lilly and Company Company Information
6.5.2 Eli Lilly and Company Description and Business Overview
6.5.3 Eli Lilly and Company Interleukin 17A Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eli Lilly and Company Interleukin 17A Product Portfolio
6.5.5 Eli Lilly and Company Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Interleukin 17A Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Johnson & Johnson Interleukin 17A Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Merck KGaA
6.7.1 Merck KGaA Company Information
6.7.2 Merck KGaA Description and Business Overview
6.7.3 Merck KGaA Interleukin 17A Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck KGaA Interleukin 17A Product Portfolio
6.7.5 Merck KGaA Recent Developments/Updates
6.8 Novartis AG
6.8.1 Novartis AG Company Information
6.8.2 Novartis AG Description and Business Overview
6.8.3 Novartis AG Interleukin 17A Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novartis AG Interleukin 17A Product Portfolio
6.8.5 Novartis AG Recent Developments/Updates
6.9 Orega Biotech SAS
6.9.1 Orega Biotech SAS Company Information
6.9.2 Orega Biotech SAS Description and Business Overview
6.9.3 Orega Biotech SAS Interleukin 17A Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Orega Biotech SAS Interleukin 17A Product Portfolio
6.9.5 Orega Biotech SAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Interleukin 17A Industry Chain Analysis
7.2 Interleukin 17A Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Interleukin 17A Production Mode & Process Analysis
7.4 Interleukin 17A Sales and Marketing
7.4.1 Interleukin 17A Sales Channels
7.4.2 Interleukin 17A Distributors
7.5 Interleukin 17A Customer Analysis
8 Interleukin 17A Market Dynamics
8.1 Interleukin 17A Industry Trends
8.2 Interleukin 17A Market Drivers
8.3 Interleukin 17A Market Challenges
8.4 Interleukin 17A Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Abeome Corporation
Affibody AB
Cell Medica Limited
Eli Lilly and Company
Johnson & Johnson
Merck KGaA
Novartis
Orega Biotech SAS
List of Tables
 Table 1. Global Interleukin 17A Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Interleukin 17A Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Interleukin 17A Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Interleukin 17A Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Interleukin 17A Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Interleukin 17A Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Interleukin 17A Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Interleukin 17A Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Interleukin 17A, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Interleukin 17A, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Interleukin 17A, Product Type & Application
 Table 12. Global Key Manufacturers of Interleukin 17A, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Interleukin 17A by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interleukin 17A as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Interleukin 17A Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Interleukin 17A Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Interleukin 17A Sales Market Share by Region (2020-2025)
 Table 19. Global Interleukin 17A Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Interleukin 17A Sales Market Share by Region (2026-2031)
 Table 21. Global Interleukin 17A Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Interleukin 17A Revenue Market Share by Region (2020-2025)
 Table 23. Global Interleukin 17A Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Interleukin 17A Revenue Market Share by Region (2026-2031)
 Table 25. North America Interleukin 17A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Interleukin 17A Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Interleukin 17A Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Interleukin 17A Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Interleukin 17A Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Interleukin 17A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Interleukin 17A Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Interleukin 17A Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Interleukin 17A Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Interleukin 17A Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Interleukin 17A Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Interleukin 17A Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Interleukin 17A Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Interleukin 17A Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Interleukin 17A Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Interleukin 17A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Interleukin 17A Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Interleukin 17A Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Interleukin 17A Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Interleukin 17A Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Interleukin 17A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Interleukin 17A Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Interleukin 17A Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Interleukin 17A Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Interleukin 17A Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Interleukin 17A Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Interleukin 17A Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Interleukin 17A Sales Market Share by Type (2020-2025)
 Table 53. Global Interleukin 17A Sales Market Share by Type (2026-2031)
 Table 54. Global Interleukin 17A Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Interleukin 17A Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Interleukin 17A Revenue Market Share by Type (2020-2025)
 Table 57. Global Interleukin 17A Revenue Market Share by Type (2026-2031)
 Table 58. Global Interleukin 17A Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Interleukin 17A Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Interleukin 17A Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Interleukin 17A Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Interleukin 17A Sales Market Share by Application (2020-2025)
 Table 63. Global Interleukin 17A Sales Market Share by Application (2026-2031)
 Table 64. Global Interleukin 17A Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Interleukin 17A Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Interleukin 17A Revenue Market Share by Application (2020-2025)
 Table 67. Global Interleukin 17A Revenue Market Share by Application (2026-2031)
 Table 68. Global Interleukin 17A Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Interleukin 17A Price (USD/Pcs) by Application (2026-2031)
 Table 70. AbbVie Inc Company Information
 Table 71. AbbVie Inc Description and Business Overview
 Table 72. AbbVie Inc Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. AbbVie Inc Interleukin 17A Product
 Table 74. AbbVie Inc Recent Developments/Updates
 Table 75. Abeome Corporation Company Information
 Table 76. Abeome Corporation Description and Business Overview
 Table 77. Abeome Corporation Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Abeome Corporation Interleukin 17A Product
 Table 79. Abeome Corporation Recent Developments/Updates
 Table 80. Affibody AB Company Information
 Table 81. Affibody AB Description and Business Overview
 Table 82. Affibody AB Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Affibody AB Interleukin 17A Product
 Table 84. Affibody AB Recent Developments/Updates
 Table 85. Cell Medica Limited Company Information
 Table 86. Cell Medica Limited Description and Business Overview
 Table 87. Cell Medica Limited Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Cell Medica Limited Interleukin 17A Product
 Table 89. Cell Medica Limited Recent Developments/Updates
 Table 90. Eli Lilly and Company Company Information
 Table 91. Eli Lilly and Company Description and Business Overview
 Table 92. Eli Lilly and Company Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Eli Lilly and Company Interleukin 17A Product
 Table 94. Eli Lilly and Company Recent Developments/Updates
 Table 95. Johnson & Johnson Company Information
 Table 96. Johnson & Johnson Description and Business Overview
 Table 97. Johnson & Johnson Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Johnson & Johnson Interleukin 17A Product
 Table 99. Johnson & Johnson Recent Developments/Updates
 Table 100. Merck KGaA Company Information
 Table 101. Merck KGaA Description and Business Overview
 Table 102. Merck KGaA Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Merck KGaA Interleukin 17A Product
 Table 104. Merck KGaA Recent Developments/Updates
 Table 105. Novartis AG Company Information
 Table 106. Novartis AG Description and Business Overview
 Table 107. Novartis AG Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Novartis AG Interleukin 17A Product
 Table 109. Novartis AG Recent Developments/Updates
 Table 110. Orega Biotech SAS Company Information
 Table 111. Orega Biotech SAS Description and Business Overview
 Table 112. Orega Biotech SAS Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Orega Biotech SAS Interleukin 17A Product
 Table 114. Orega Biotech SAS Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Interleukin 17A Distributors List
 Table 118. Interleukin 17A Customers List
 Table 119. Interleukin 17A Market Trends
 Table 120. Interleukin 17A Market Drivers
 Table 121. Interleukin 17A Market Challenges
 Table 122. Interleukin 17A Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Interleukin 17A
 Figure 2. Global Interleukin 17A Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Interleukin 17A Market Share by Type: 2024 & 2031
 Figure 4. ABY-035 Product Picture
 Figure 5. CNTO-6785 Product Picture
 Figure 6. DLX-2882 Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Interleukin 17A Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Interleukin 17A Market Share by Application: 2024 & 2031
 Figure 10. Chronic Pain
 Figure 11. Liver Cancer
 Figure 12. Kidney Cancer
 Figure 13. Others
 Figure 14. Global Interleukin 17A Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Interleukin 17A Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Interleukin 17A Sales (2020-2031) & (K Pcs)
 Figure 17. Global Interleukin 17A Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Interleukin 17A Report Years Considered
 Figure 19. Interleukin 17A Sales Share by Manufacturers in 2024
 Figure 20. Global Interleukin 17A Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Interleukin 17A Players: Market Share by Revenue in Interleukin 17A in 2024
 Figure 22. Interleukin 17A Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Interleukin 17A Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Interleukin 17A Sales Market Share by Country (2020-2031)
 Figure 25. North America Interleukin 17A Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Interleukin 17A Sales Market Share by Country (2020-2031)
 Figure 29. Europe Interleukin 17A Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Interleukin 17A Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Interleukin 17A Revenue Market Share by Region (2020-2031)
 Figure 37. China Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Interleukin 17A Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Interleukin 17A Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Interleukin 17A Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Interleukin 17A Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Interleukin 17A Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Interleukin 17A by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Interleukin 17A by Type (2020-2031)
 Figure 59. Global Interleukin 17A Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Interleukin 17A by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Interleukin 17A by Application (2020-2031)
 Figure 62. Global Interleukin 17A Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Interleukin 17A Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Interleukin 1 Alpha Market Research Report 2024
Global Stem Cell Cytokines Market Research Report 2024
Global Interleukin 2 Receptor Subunit Alpha Market Research Report 2025
Global Injection Human Interleukin 2 Market Research Report 2025
Global Recombinant Human Interleukin 11 for Injection Market Research Report 2025
Global Interleukin 17 Inhibitors Market Research Report 2024
Global Cytokine Inhibitor Market Research Report 2025
Global IL 17 Targeting Biological Drugs Market Research Report 2024
Global Cytokine Detection Service Market Research Report 2025
Global Peptide Analysis Market Research Report 2025
Global Phytohemagglutinin PHA Market Research Report 2025
Global Hepatitis A immunoglobulin Market Research Report 2025
Global Health Product for Immune Market Research Report 2024
Global Interleukin 17A IL 17A ELISA Kit Market Research Report 2024
Global CD79a Antibody Market Research Report 2024
Global 17α Hydroxyprogesterone 17α OHP Market Research Report 2025
Organoid Cytokines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cytokine Detection Kit Market Research Report 2024
Global Interferon Alpha 2a Market Research Report 2024
Global Recombinant Human Interleukin 2 Injection Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions